Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05200312
What this trial is testing

A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell Lymphoma

Who this might be right for
Non Hodgkin LymphomaDiffuse Large B Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 36
Testing effectiveness (Phase 2)UnknownNCT03540849
What this trial is testing

BV After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hodgkin Lymphoma
University Hospital, Caen 58
Very early researchActive Not RecruitingNCT04161248
What this trial is testing

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Canadian Cancer Trials Group 40
Early research (Phase 1)Study completedNCT01898078
What this trial is testing

Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorsLymphoma
Millennium Pharmaceuticals, Inc. 26
Testing effectiveness (Phase 2)Ended earlyNCT02592876
What this trial is testing

Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma, B-cellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular, Grade 3b+1 more
Seagen Inc. 81
Early research (Phase 1)Study completedNCT03939026
What this trial is testing

Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

Who this might be right for
Relapsed/Refractory Large B Cell LymphomaRelapsed/Refractory Follicular Lymphoma
Allogene Therapeutics 50
Not applicableLooking for participantsNCT07258043
What this trial is testing

Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphobkastic LeukemiaLeukemiaOverall Survival
Hospital General de Mexico 45
Very early researchLooking for participantsNCT04227015
What this trial is testing

CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma
He Huang 72
Not applicableLooking for participantsNCT06788652
What this trial is testing

Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

Who this might be right for
Mantle Cell Lymphoma (MCL)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 300
Not applicableEnrolling By InvitationNCT05509855
What this trial is testing

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Lymphoblastic Lymphoma
Allotera Therapeutics 44
Very early researchUnknownNCT06045585
What this trial is testing

JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Lymphoma
Guangdong Second Provincial General Hospital 20
Early research (Phase 1)Study completedNCT04626843
What this trial is testing

Intermittent Fasting and CLL/SLL

Who this might be right for
NeoplasmsLeukemia, Lymphocytic, ChronicLymphoma, Small Lymphocytic+3 more
Eleah Stringer 15
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Very early researchLooking for participantsNCT06532643
What this trial is testing

Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma

Who this might be right for
Relapsed/Refractory Lymphoma
Shanghai First Song Biotechnology Co., LTD 9
Testing effectiveness (Phase 2)Study completedNCT04661943
What this trial is testing

Maintenance Therapy of Chidamide in Patients With HBV Positive Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Ou Bai, MD/PHD 30
Testing effectiveness (Phase 2)Looking for participantsNCT02693535
What this trial is testing

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Who this might be right for
Lymphoma, Non-HodgkinMultiple MyelomaAdvanced Solid Tumors
American Society of Clinical Oncology 4,200
Early research (Phase 1)Study completedNCT03010176
What this trial is testing

Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)

Who this might be right for
Solid TumorsLymphoma
Merck Sharp & Dohme LLC 156
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07034508
What this trial is testing

A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 134
Testing effectiveness (Phase 2)Ended earlyNCT02282358
What this trial is testing

Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Who this might be right for
LymphomaRelapsed and RefractoryDiffuse Large B-Cell Lymphoma and Follicular Lymphoma
Memorial Sloan Kettering Cancer Center 7
Not applicableNo Longer AvailableNCT03914885
What this trial is testing

Compassionate Use Re-Infusion of ATLCAR.CD30

Who this might be right for
Hodgkin Lymphoma, Adult
UNC Lineberger Comprehensive Cancer Center
Next Page